We are live on
!
Find out more
MITO
Stealth BioTherapeutics Corp. ADS
MITO
MITO
Delisted
MITO was delisted on the 15th of November, 2022.
10 hedge funds and large institutions have $835K invested in Stealth BioTherapeutics Corp. ADS in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
11% more funds holding
Funds holding: 9 → 10 (+1)
45% less capital invested
Capital invested by funds: $1.53M → $835K (-$697K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$20.9K |
| 2 |
HF
HRT Financial
New York
|
+$5.72K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.03K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$285K |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$60.1K |
| 3 |
Millennium Management
New York
|
-$40K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$12.3K |
| 5 |
PC
PA Capital
Richmond,
Virginia
|
-$7.9K |